NCT01998035 2024-08-22Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid MalignanciesColumbia UniversityPhase 1/2 Terminated58 enrolled 11 charts
NCT00383565 2014-05-20FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 2 Terminated9 enrolled 9 charts